We are live on
!
Find out more
LS
Leelyn Smith Portfolio holdings
AUM
$822M
Turnover
11.52%
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
+6.37%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$336M
AUM Growth
+$23.3M
(+7.4%)
Cap. Flow
+$15.2M
Cap. Flow
% of AUM
4.53%
Top 10 Holdings %
Top 10 Hldgs %
40.79%
Holding
397
New
32
Increased
145
Reduced
77
Closed
9
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.55M |
| 2 |
Merck
MRK
|
+$1.96M |
| 3 |
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
|
+$1.95M |
| 4 |
Alibaba
BABA
|
+$1.9M |
| 5 |
ARK Innovation ETF
ARKK
|
+$1.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles Schwab
SCHW
|
+$2.01M |
| 2 |
RTX Corp
RTX
|
+$1.65M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.17M |
| 4 |
First Trust Cloud Computing ETF
SKYY
|
+$863K |
| 5 |
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
|
+$830K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.04% |
| 2 | Technology | 10.61% |
| 3 | Healthcare | 7.68% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Financials | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Halliburton
HAL
$27.4B
| $2K | ﹤0.01% |
70
| – | – |
2020 Q4
1 quarter
|
|
352
MGM Resorts International
MGM
$7.42B
| $2K | ﹤0.01% |
47
| – | – |
2020 Q2
3 quarters
|
|
353
Momentus
MNTS
$61.7M
| – | – |
0
| – | – |
2020 Q4
1 quarter
|
|
354
NGL Energy Partners
NGL
$1.85B
| $2K | ﹤0.01% |
1,000
| – | – |
2019 Q4
5 quarters
|
|
355
Simplify US Equity PLUS Convexity ETF
SPYC
$82.2M
| $2K | ﹤0.01% |
+72
| New | +$2K |
2021 Q1
0 quarters
|
|
356
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $2K | ﹤0.01% |
200
| – | – |
2020 Q4
1 quarter
|
|
357
Viatris
VTRS
$20.9B
| $2K | ﹤0.01% |
133
-4,501
| -97% | -$73.4K |
2019 Q4
5 quarters
|
|
358
Aimco
AIV
$244M
| $1K | ﹤0.01% |
234
| – | – |
2019 Q4
5 quarters
|
|
359
Advanced Micro Devices
AMD
$918B
| $1K | ﹤0.01% |
+10
| New | +$861 |
2021 Q1
0 quarters
|
|
360
DELISTED
Avanos Medical
AVNS
| $1K | ﹤0.01% |
32
| – | – |
2019 Q4
5 quarters
|
|
361
JPMorgan BetaBuilders Canada ETF
BBCA
$11.4B
| $1K | ﹤0.01% |
+22
| New | +$1.25K |
2021 Q1
0 quarters
|
|
362
Citigroup
C
$207B
| $1K | ﹤0.01% |
10
| – | – |
2019 Q4
5 quarters
|
|
363
DELISTED
ChampionX
CHX
| $1K | ﹤0.01% |
50
| – | – |
2020 Q4
1 quarter
|
|
364
eBay
EBAY
$54.7B
| $1K | ﹤0.01% |
+15
| New | +$870 |
2021 Q1
0 quarters
|
|
365
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.1B
| $1K | ﹤0.01% |
11
| – | – |
2020 Q4
1 quarter
|
|
366
Fuel Tech
FTEK
$44.3M
| $1K | ﹤0.01% |
200
| – | – |
2019 Q4
5 quarters
|
|
367
General Motors
GM
$73.4B
| $1K | ﹤0.01% |
+20
| New | +$1.06K |
2021 Q1
0 quarters
|
|
368
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.07B
| $1K | ﹤0.01% |
12
| – | – |
2020 Q3
2 quarters
|
|
369
DELISTED
iRobot
IRBT
| $1K | ﹤0.01% |
+5
| New | +$568 |
2021 Q1
0 quarters
|
|
370
Johnson Controls International
JCI
$89.4B
| $1K | ﹤0.01% |
24
| – | – |
2020 Q4
1 quarter
|
|
371
Otis Worldwide
OTIS
$26.8B
| $1K | ﹤0.01% |
15
-39
| -72% | -$2.55K |
2020 Q2
3 quarters
|
|
372
Regeneron Pharmaceuticals
REGN
$82B
| $1K | ﹤0.01% |
3
| – | – |
2020 Q3
2 quarters
|
|
373
Under Armour
UAA
$2.1B
| $1K | ﹤0.01% |
41
| – | – |
2020 Q3
2 quarters
|
|
374
Wynn Resorts
WYNN
$7.93B
| $1K | ﹤0.01% |
10
| – | – |
2020 Q3
2 quarters
|
|
375
Adient
ADNT
$1.4B
| $0 | ﹤0.01% |
2
| – | – |
2020 Q4
1 quarter
|
|
Similar funds
SCM
SCP
GSWM
HVIA
MGAM
IA
WRPWM
RP
Leelyn Smith's Q1 2021 Portfolio in Review
As of Q1 2021, Leelyn Smith held 397 positions worth $336M, up 7.4% from $313M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Leelyn Smith deployed $15.2M of net new capital in Q1 2021, opening 32 new positions and adding to 145 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 52% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Charles Schwab, an estimated $2.01M trimmed.
- Leelyn Smith's largest Q1 2021 buy was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.
- Leelyn Smith added most to Invesco QQQ Trust in Q1 2021, an estimated $2.55M increase.
- Leelyn Smith's biggest Q1 2021 reduction was Charles Schwab, cutting an estimated $2.01M.
- Leelyn Smith fully exited Colgate-Palmolive in Q1 2021, selling an estimated $94K.
- Leelyn Smith's ten largest holdings make up 41% of its $336M portfolio in Q1 2021.
- Leelyn Smith opened 32 new positions and closed 9 in Q1 2021.
- Leelyn Smith's portfolio value rose 7.4% quarter-over-quarter to $336M.
Based on Leelyn Smith's 13F filing for Q1 2021, filed 5 May 2021.